Inadequate quality of administration of intranasal corticosteroid sprays
Authors Rollema C, van Roon EN, de Vries TW
Received 21 October 2018
Accepted for publication 21 January 2019
Published 3 April 2019 Volume 2019:12 Pages 91—94
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Amrita Dosanjh
Corine Rollema,1,2 Eric N van Roon,1,2 Tjalling W de Vries3
1Department of Clinical Pharmacy and Pharmacology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands; 2Groningen Research Institute of Pharmacy, Department Pharmaco therapy, Epidemiology and Economy, University of Groningen, Groningen, The Netherlands; 3Department of Paediatrics, Medical Centre Leeuwarden, Leeuwarden, The Netherlands
Purpose: Considering the fact that many mistakes are still being made by asthmatic patients when inhaling lung medication, it is important to gain insight into current techniques used to administer intranasal corticosteroid sprays (INCS) in allergic rhinitis patients. In this study, we aimed to get insight into daily use of INCS and to determine if improvement of the technique is required.
Patients and methods: A checklist, based on available patient information leaflets (PILs) and literature, was used to determine the participants’ application of the techniques used to administer INCS. These applied techniques were compared with steps described in PILs and recommended essential steps.
Results: In the overall population (64 participants) four participants (6%) carried out all steps as described in the PIL and seven participants (11%) carried out all recommended essential steps.
Conclusion: The technique used to administer INCS is inadequate. Uniform and generally applicable instructions are needed and patients using INCS should be guided better.
Keywords: intranasal corticosteroid sprays, allergic rhinitis, administration techniques, quality of administration
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]